Analysis of VEGF polymorphisms, tumor expression of VEGF mRNA and colorectal cancer susceptibility in a Swedish population

Molecular Medicine Reports

Volumn 2, Issue 3, 2009, Pages 435-439

  Ungerbäck, Jonas ^a   Elander, Nils ^a   Dimberg, Jan ^b   Söderkvist, Peter ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b JÖNKÖPING UNIVERSITY   (Sweden)

Author keywords

Colorectal cancer; Haplotype analysis; mRNA; Single nucleotide polymorphism; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CANCER PATIENT; CANCER SUSCEPTIBILITY; CANCER TISSUE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POPULATION BASED CASE CONTROL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

EID: 69249130516     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000118     Document Type: Article

References (31)

1. Stoeltzing O, Liu W, Reinmuth M, et al: Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis. Ann Surg Oncol 10: 722-733, 2003.
2. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC and Abraham JA: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991. (Pubitemid 21907041)
3. Mohammadi M, Ollier WE and Hutchinson IV: A functional association study of VEGF gene promoter polymorphisms with VEGF expression by stimulated pbm cells. Hum Immunol 64: S125, 2003.
4. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B and Pilger E: A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37: 443-448, 2000. (Pubitemid 32037619)
5. Watson CJ, Webb N, Bottomley MJ and Brenchley P: Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12: 1232-1235, 2000. (Pubitemid 30611801)
6. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V and Hutchinson IV: Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 60: 1245-1249, 1999.
7. Stevens A, Soden J, Brenchley PE, Ralph S and Ray DW: Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63: 812-816, 2003. (Pubitemid 36231981)
8. Jin Q, Hemminki K, Enquist E, et al: Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11: 3647-3653, 2005. (Pubitemid 40685580)
9. Sfar S, Hassen E, Saad H, Mosbah F and Chouchane L: Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine 35: 21-28, 2006. (Pubitemid 44485531)
10. Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E and Sivridis E: VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small lung cancer. Lung Cancer 46: 293-298, 2004. (Pubitemid 39487303)
11. Howell WM, Bateman AC, Turner SJ, Collins A and Theaker JM: Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumor development in cutaneous malignant melanoma. Genes Immun 3: 229-232, 2002. (Pubitemid 38961136)
12. Butt C, Lim S, Greenwood CM and Rahman P: VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. BMC Muscoloskelet Disord 8: 1, 2007. (Pubitemid 46169616)
13. Han SW, Kim GW, Seo JS, Kim SJ, Sa KH, Park JY, et al: VEGF gene polymorphisms and susceptibility to rheumatoid arthrithis. Rheumatology 43: 1173-1179, 2004.
14. Medford AR, Keen LJ, Bidwell JL and Millar AB: Vascular endothelial growth factor gene polymorphisms and acute respiratory distress syndrome. Thorax 60: 244-248, 2005. (Pubitemid 40380286)
15. Nam EJ, Han SW, Kim SU, Cho JH, Sa KH, Lee WK, et al: Association of vascular endothelial growth factor polymorphisms with Behcet disease in a Korean population. Hum Immunol 66: 1068-1073, 2005. (Pubitemid 43005010)
16. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics. CA Cancer J Clin 55: 74-108, 2005.
17. Nakamura M, Abe Y and Tokunaga T: Pathological significance of vascular endothelial growth factor A isoform expression in human cancer. Pathol Int 52: 331-339, 2002. (Pubitemid 34748215)
18. Hanrahan V, Currie MJ, Gunningham SP, et al: The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C and VEGF-D in the adenomacarcinoma sequence during colorectal cancer progression. J Pathol 200: 183-194, 2003. (Pubitemid 36748027)
19. George ML, Tutton MG, Janssen F, et al: VEGF-A, VEGF-C and VEGF-D in colorectal cancer progression. Neoplasia 3: 420-427, 2001.
20. Garcia V, Garcia JM, Silva J, Pena C, Dominguez G, Lorenzo Y, et al: Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis. J Cancer Res Clin Oncol 134: 1165-1171, 2008.
21. Longo R and Gasparini G: Anti-VEGF therapy: the search for clinical biomarkers. Expert Rev Mol Diagn 8: 301-314, 2008. (Pubitemid 351724709)
22. Dimberg J, Hugander A, Sirsjo A and Soderkvist P: Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer. Anticancer Res 21: 911-915, 2001. (Pubitemid 32494189)
23. Stephens M, Smith N and Donnelly P: A new statistical method for haplotype reconstruction from population genotype data. Am J Hum Gen 73: 1162-1169, 2001. (Pubitemid 32289743)
24. Dupont WD and Plummer WD Jr: Power and sample size calculations: a review and computer program. Control Clin Trials 11: 116-128, 1990.
25. Yamamori M, Sakaeda T, Nakamura T, et al: Association of VEGF genotype with mRNA level in colorectal adenocarcinomas. Biochem Biophys Res Commun 325: 144-150, 2004. (Pubitemid 39441172)
26. Cacev T, Loncar B, Seiwerth S, Spaventi S and Kapitanovic S: Vascular endothelial growth factor polymorphisms -1154 G/A and -460 C/T are not associated with VEGF mRNA expression and susceptibility to sporadic colon cancer. DNA Cell Biol 27: 569-574, 2008.
27. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD and Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996. (Pubitemid 26272112)
28. Barr LF, Campbell SE, Diette GB, Gabrielson EW, Kim S, Shim H and Dang CV: c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression. Cancer Res 60: 143-149, 2000. (Pubitemid 30058744)
29. Chae YS, Kim JG, Sohn SK, Cho YY, Ahn BM, Moon JH, et al: Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci 23: 421-427, 2008.
30. Hofmann G, Langsenlehner U, Renner W, Langsenlehner T, Yazdani-Biuki B and Clar H: Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clin Oncol 134: 591-595, 2008.
31. Maltese P, Canestrari E, Ruzzo A, Graziano AF, Loupakis F Tonini G, et al: VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. Int J Colorectal Dis: Epub ahead of print, 2008.